FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature

Abstract : This paper follows the immunotherapy symposium held during the European Association of Nuclear Medicine (EANM) 2017 Annual Congress. The biological basis of the immune checkpoint inhibitors and the drugs most frequently used for the treatment of solid tumours are reviewed. The issues of pseudoprogression (frequency, timeline), hyperprogression and immune-related side effects are discussed, as well as their implications for patient management. A review of the recent literature on the use of FDG PET for assessment of immunotherapy is presented, and recommendations are provided for assessing tumour response and reporting immune-related side effects with FDG PET based on published data and experts' experience. Representative clinical cases are also discussed.
Document type :
Journal articles
Complete list of metadatas

Cited literature [47 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02101049
Contributor : Myriam Bodescot <>
Submitted on : Tuesday, November 26, 2019 - 2:53:06 PM
Last modification on : Wednesday, December 4, 2019 - 9:52:03 AM

File

Aide2019_Article_FDGPETCTForAs...
Publication funded by an institution

Identifiers

Citation

Nicolas Aide, Rodney Hicks, Christophe Le Tourneau, Stéphanie Lheureux, Stefano Fanti, et al.. FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature. European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2019, 46 (1), pp.238-250. ⟨10.1007/s00259-018-4171-4⟩. ⟨inserm-02101049⟩

Share

Metrics

Record views

92

Files downloads

16